Physician profile
Macare E Lumbrezer
NPI 1457519092
$209.97
in general payments reported to CMS, 2019-2025
7 companies · $15.64 in 2025
The $15.64 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.72 · 2020: $11.31 · 2021: $59.55 · 2022: $16.79 · 2023: $51.96 · 2025: $15.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35.00 · Food and Beverage: $32.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35.00 |
| Food and Beverage | $32.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3m Company | $44.96 | 2021 | |
| Dentsply Sirona INC | $42.36 | 2019-2023 | Midwest E Plus |
| Sonendo INC | $40.63 | 2019 | |
| Align Technology, INC. | $35.00 | 2023 | Itero, Invisalign |
| Kerr Corporation | $16.79 | 2022 | |
| Voco America INC. | $15.64 | 2025 | Meron Plus Qm, Voco Profluorid Varnish, Admira Fusion X-Tra |
| Colgate Oral Pharmaceuticals, INC. | $14.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Macare Lumbrezer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.